AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇬🇭
Neostigmine Methylsulphate in Ghana
2 products registered with FDA Ghana — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| NEOSTIGMINE METHYLSULPHATE FESENIUS 25/.L INJECTION (Each ampoule contains Neostigmine methylsulphate 2.5mg/ml) | UNKNOWN-ffa29af5 | — | active | 1 Apr 2027 |
| NEOSTIGMINE METHYLSULPHATE FESENIUS 25/.L INJECTION (Each ampoule contains Neostigmine methylsulphate 2.5mg/ml) | UNKNOWN-f8438ea9 | — | active | 1 Apr 2027 |
Neostigmine Methylsulphate — FDA Ghana Registration Details
FDA Ghana (Ghana) has 2 registered products containing Neostigmine Methylsulphate, of which 2 are currently active. Data is sourced directly from the official FDA Ghana drug register and refreshed daily.
Track Neostigmine Methylsulphate registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.